Biolase Inc (BIOL)
0.1456
-0.01
(-3.64%)
USD |
NASDAQ |
Apr 24, 16:00
0.1413
0.00 (0.00%)
After-Hours: 20:00
Biolase Research and Development Expense (Quarterly): 1.652M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.652M |
| September 30, 2023 | 1.362M |
| June 30, 2023 | 1.444M |
| March 31, 2023 | 1.547M |
| December 31, 2022 | 2.088M |
| September 30, 2022 | 1.979M |
| June 30, 2022 | 1.653M |
| March 31, 2022 | 1.544M |
| December 31, 2021 | 1.542M |
| September 30, 2021 | 1.54M |
| June 30, 2021 | 1.162M |
| March 31, 2021 | 1.803M |
| December 31, 2020 | 1.051M |
| September 30, 2020 | 0.963M |
| June 30, 2020 | 0.69M |
| March 31, 2020 | 0.991M |
| December 31, 2019 | 1.10M |
| September 30, 2019 | 1.126M |
| June 30, 2019 | 1.124M |
| March 31, 2019 | 1.424M |
| December 31, 2018 | 1.276M |
| September 30, 2018 | 1.277M |
| June 30, 2018 | 1.361M |
| March 31, 2018 | 1.289M |
| December 31, 2017 | 1.389M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.601M |
| June 30, 2017 | 1.81M |
| March 31, 2017 | 1.429M |
| December 31, 2016 | 2.298M |
| September 30, 2016 | 1.715M |
| June 30, 2016 | 1.90M |
| March 31, 2016 | 1.886M |
| December 31, 2015 | 1.75M |
| September 30, 2015 | 1.756M |
| June 30, 2015 | 1.974M |
| March 31, 2015 | 1.803M |
| December 31, 2014 | 1.35M |
| September 30, 2014 | 1.276M |
| June 30, 2014 | 0.978M |
| March 31, 2014 | 0.973M |
| December 31, 2013 | 1.042M |
| September 30, 2013 | 0.977M |
| June 30, 2013 | 1.005M |
| March 31, 2013 | 1.005M |
| December 31, 2012 | 1.027M |
| September 30, 2012 | 1.195M |
| June 30, 2012 | 1.272M |
| March 31, 2012 | 1.19M |
| December 31, 2011 | 1.073M |
| September 30, 2011 | 1.052M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.69M
Minimum
Jun 2020
2.088M
Maximum
Dec 2022
1.387M
Average
1.444M
Median
Jun 2023
Research and Development Expense (Quarterly) Benchmarks
| Dentsply Sirona Inc | 43.00M |
| Milestone Scientific Inc | 0.1769M |
| Wellness Center USA Inc | -- |
| Envista Holdings Corp | 20.20M |
| Sonendo Inc | 2.514M |